Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Cephradine

Cephradine: An In-Depth Look at the First-Generation Cephalosporin Antibiotic

Cephradine is a first-generation cephalosporin antibiotic that has been widely used in clinical practice for the treatment of various bacterial infections. It shares many characteristics with other cephalosporins, but it also has its own distinct clinical applications, mechanism of action, and pharmacological properties.

Introduction to Cephradine

Cephradine, also known as cephradine, is a first-generation cephalosporin that is primarily used for treating infections caused by susceptible bacteria. It is part of the broader class of beta-lactam antibiotics, which include penicillins and other cephalosporins. Like other beta-lactams, Cephradine works by inhibiting the synthesis of bacterial cell walls, leading to bacterial cell death. First introduced in the 1970s, Cephradine has been a cornerstone treatment for infections involving gram-positive bacteria and some gram-negative bacteria. However, with the development of newer antibiotics, its usage has become more selective, with other cephalosporins and antibiotics increasingly being preferred for certain types of infections.

Chemical Structure and Properties

Cephradine is chemically classified as (6R,7R)-3-{[(3,4-dihydro-4-oxo-3-pyrimidinyl)thio]methyl}-7-[(2-phenylthio)acetamido]-3-cephem-4-carboxylic acid. It is a derivative of 7-aminocephalosporanic acid, a core structure shared by all cephalosporins. Cephradine contains a β-lactam ring, which is essential for its antibacterial activity. This structure enables the antibiotic to bind to penicillin-binding proteins (PBPs), thus interfering with cell wall synthesis and promoting bacterial cell lysis. It is available in oral and parenteral forms, but due to poor bioavailability when taken orally, it is often administered intravenously or intramuscularly for serious infections. The molecular characteristics contribute to its relatively short half-life and rapid elimination from the body.

Mechanism of Action

Cephradine functions by inhibiting bacterial cell wall synthesis, similar to other beta-lactam antibiotics. The cell wall is crucial for maintaining the structural integrity of bacterial cells, particularly in prokaryotic organisms. Inhibition of cell wall synthesis results in weakened bacterial cells, which are susceptible to osmotic pressure and eventually undergo lysis.

Cephradine binds to penicillin-binding proteins (PBPs), which are enzymes involved in the final steps of peptidoglycan biosynthesis. By binding to these PBPs, Cephradine prevents the formation of a stable cell wall, leading to bacterial death. Because of its beta-lactam structure, Cephradine is considered bactericidal, meaning it kills bacteria rather than just inhibiting their growth. Its effectiveness is primarily against gram-positive cocci and some gram-negative bacilli. Cephradine, however, is less effective against organisms producing β-lactamases, enzymes that degrade the beta-lactam ring and render the antibiotic inactive.

Spectrum of Activity

Cephradine is most effective against a variety of gram-positive bacteria, but its activity against gram-negative bacteria is more limited compared to newer cephalosporins.

Strong Activity Against:

  • Staphylococcus aureus (methicillin-sensitive strains, MSSA)

  • Streptococcus pyogenes

  • Streptococcus pneumoniae

  • Streptococcus agalactiae

Moderate Activity Against:

  • Escherichia coli

  • Klebsiella pneumoniae

  • Proteus mirabilis

Limited or No Activity Against:

  • Methicillin-resistant Staphylococcus aureus (MRSA)

  • Pseudomonas aeruginosa

  • Enterococcus species

  • Anaerobic bacteria

  • Certain beta-lactamase-producing strains

Cephradine’s spectrum is similar to other first-generation cephalosporins but lacks the broader activity seen with second- and third-generation cephalosporins. It is generally considered effective for treating infections caused by gram-positive cocci but is not the best choice for infections caused by gram-negative pathogens.

Pharmacokinetics

Cephradine has several pharmacokinetic properties that affect its clinical use:

  • Absorption: Cephradine is well absorbed from the gastrointestinal tract, but its bioavailability is relatively low, making it less effective when taken orally for systemic infections. For more severe infections, intravenous (IV) or intramuscular (IM) administration is preferred.

  • Distribution: Cephradine is widely distributed in the body, with good penetration into tissues such as bone, skin, and soft tissues. It can cross the placenta and is excreted in breast milk.

  • Half-life: The elimination half-life of Cephradine is approximately 1–2 hours, which is relatively short. This means that it may need to be administered multiple times per day to maintain effective drug levels in the bloodstream.

  • Excretion: Cephradine is primarily excreted unchanged by the kidneys. It is important to adjust the dosage in patients with renal impairment to avoid drug accumulation and potential toxicity.

Clinical Uses

Cephradine is used to treat a variety of infections, primarily those caused by gram-positive bacteria. Its primary clinical indications include:

1. Skin and Soft Tissue Infections (SSTIs)

Cephradine is highly effective for treating skin infections such as cellulitis, abscesses, and wound infections caused by susceptible strains of Staphylococcus aureus and Streptococcus pyogenes.

2. Upper and Lower Respiratory Tract Infections

Cephradine is sometimes used in treating upper respiratory tract infections, such as pharyngitis and tonsillitis, as well as lower respiratory tract infections like pneumonia, especially when the causative organisms are known to be sensitive to the antibiotic.

3. Urinary Tract Infections (UTIs)

It is used for treating uncomplicated urinary tract infections (UTIs) caused by E. coli, Klebsiella pneumoniae, and Proteus mirabilis, although other antibiotics may be preferred in complicated cases.

4. Bone and Joint Infections

For osteomyelitis or septic arthritis caused by MSSA, Cephradine may be used as an alternative to other beta-lactam antibiotics.

5. Prophylactic Use in Surgery

Cephradine is sometimes used as a prophylactic antibiotic in surgeries where infections caused by gram-positive bacteria are a concern. This includes orthopedic, cardiac, and abdominal surgeries.

Dosing Guidelines

Cephradine dosing is typically based on the severity of the infection and the route of administration. The general dosing guidelines are as follows:

For Oral Administration:

  • Adults: 250 mg to 500 mg every 6 hours.

  • Pediatrics: The pediatric dose is typically based on weight, ranging from 25 mg/kg/day to 50 mg/kg/day divided into multiple doses.

For Intravenous (IV) or Intramuscular (IM) Administration:

  • Adults: 500 mg to 1 gram every 8 hours.

  • Pediatrics: Again, based on body weight, generally 25–50 mg/kg/day in divided doses.

In cases of renal impairment, the dose should be adjusted to account for slower clearance.

Side Effects and Adverse Reactions

Like all antibiotics, Cephradine can cause side effects, although it is generally well tolerated.

Common Side Effects:

  • Gastrointestinal issues: Nausea, vomiting, diarrhea, and abdominal discomfort.

  • Rash or skin reactions: Mild rashes or itching may occur in some patients.

  • Injection site reactions: Pain, swelling, or redness at the site of intravenous or intramuscular administration.

Serious Adverse Effects:

  • Hypersensitivity reactions: Anaphylaxis or severe allergic reactions, though rare, can occur in sensitive individuals, especially those with a history of penicillin allergy.

  • Clostridioides difficile-associated diarrhea (CDAD): Like many antibiotics, Cephradine can disrupt normal gut flora, leading to opportunistic infections by C. difficile.

  • Renal toxicity: Cephradine is primarily eliminated by the kidneys, so in patients with renal impairment, the drug may accumulate, leading to potential nephrotoxicity.

  • Blood dyscrasias: Rarely, Cephradine may cause neutropenia or thrombocytopenia, particularly with prolonged use.

Resistance Patterns

Resistance to Cephradine is becoming more common, particularly among gram-negative bacteria that produce beta-lactamase enzymes capable of inactivating the drug. Resistance mechanisms include:

  • Beta-lactamase production: Enzymes that hydrolyze the beta-lactam ring, rendering Cephradine ineffective.

  • Alterations in penicillin-binding proteins (PBPs): Changes in the structure of PBPs may reduce Cephradine’s ability to bind to them.

  • Efflux pumps: Some bacteria can pump the drug out of the cell, preventing its accumulation to therapeutic levels.

Despite these resistance mechanisms, Cephradine remains a useful antibiotic in many clinical settings, particularly for treating infections caused by MSSA and Streptococcus species.

Conclusion

Cephradine is a reliable first-generation cephalosporin antibiotic with a long history of effective use in treating gram-positive infections, especially in soft tissue, respiratory, and urinary tract infections. While its spectrum is more limited compared to newer cephalosporins, it remains an essential agent in the fight against bacterial infections. As with all antibiotics, prudent use is essential to avoid resistance development, and it is important to consider factors such as renal function and the potential for allergic reactions when prescribing Cephradine. With proper management, Cephradine continues to be an invaluable tool in modern antimicrobial therapy.